Literature DB >> 23161577

Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus.

J K Alkaabi1, S Alkindi, N Al Riyami, F Zia, L M A Balla, S M Balla.   

Abstract

We present a case of a pregnant woman at 27 weeks of gestation with systemic lupus erythematosus who developed severe thrombocytopenia presenting with melena, epistaxis, gum bleeding and frank hematuria. She was resistant to most treatment modalities, including steroids, intravenous immunoglobulins (IVIG), rituximab, IV cyclophosphamide and eltrombopag. She responded to romiplostim with normalization of her platelet count, which enabled her to be delivered safely at 34 weeks of gestation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161577     DOI: 10.1177/0961203312463621

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

Review 2.  The pharmacology and clinical application of thrombopoietin receptor agonists.

Authors:  Caizheng Li; Li Zheng
Journal:  Int J Hematol       Date:  2014-09-18       Impact factor: 2.490

3.  Severe Case of Autoimmune Thrombocytopenia First Diagnosed in Pregnancy.

Authors:  K Bolten; A Salama; A Thomas; J Eucker; W Henrich
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-12       Impact factor: 2.915

4.  Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature review.

Authors:  Su J Chua; Mark R Morton; John Svigos; David M Ross; Simon Kane
Journal:  Obstet Med       Date:  2018-05-29

5.  Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag.

Authors:  Phillip Scheinberg; Cristiane Carvalho Singulane; Luis Sergio Guedes Barbosa; Morton Scheinberg
Journal:  Clin Rheumatol       Date:  2014-04-17       Impact factor: 2.980

6.  Refractory severe immune thrombocytopenia in a twin pregnancy.

Authors:  Patrick Harrington; Catherine Nelson-Piercy; Catherine Williamson; Nichola Cooper; Rachel Kesse-Adu; Susan Robinson
Journal:  Obstet Med       Date:  2017-07-10

Review 7.  Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndrome.

Authors:  Andrew P Vreede; Paula L Bockenstedt; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

8.  Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review.

Authors:  Satoshi Shibata; Takuya Misugi; Takahiko Nakane; Masayuki Hino; Daisuke Tachibana
Journal:  Cureus       Date:  2022-02-22

Review 9.  Lupus thrombocytopenia: pathogenesis and therapeutic implications.

Authors:  Nikolaos Galanopoulos; Anna Christoforidou; Zoe Bezirgiannidou
Journal:  Mediterr J Rheumatol       Date:  2017-03-28

10.  Hematological disorders in patients with systemic lupus erythematosus.

Authors:  Fozya Bashal
Journal:  Open Rheumatol J       Date:  2013-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.